Minerva Neurosciences, Inc. (NERV) financial statements and ratios from SEC XBRL: revenue $948122.00 (TTM), net margin -30947.8%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $948122.00 |
| Net Margin | -30947.8% |
| Price / Sales | 118.91 |
| Altman Z-Score | -8.83 (distress) |
| Sector P/E (Healthcare) | 21.7 |
NERV overview · NERV earnings · NERV KPIs · NERV investor relations · NERV ownership · NERV peers · NERV filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.